Michelle Ferguson

2.1k total citations
32 papers, 928 citations indexed

About

Michelle Ferguson is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michelle Ferguson has authored 32 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Reproductive Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michelle Ferguson's work include Ovarian cancer diagnosis and treatment (10 papers), PARP inhibition in cancer therapy (9 papers) and BRCA gene mutations in cancer (6 papers). Michelle Ferguson is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), PARP inhibition in cancer therapy (9 papers) and BRCA gene mutations in cancer (6 papers). Michelle Ferguson collaborates with scholars based in United Kingdom, United States and Canada. Michelle Ferguson's co-authors include Gillian Smith, Probir Chakravarty, Susan E. Bray, Aparajitha Vaidyanathan, Anne‐Louise Gannon, C. Roland Wolf, Susan M. Domchek, Kassondra Meyer, Yvette Drew and Helen K. Angell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Michelle Ferguson

30 papers receiving 913 citations

Peers

Michelle Ferguson

ONCOL

PRM

IMMUN

Katherine Karakasis Canada

Hongyan Cheng China

Maria Ornella Nicoletto Italy

Tomoko Freshwater United States

Shane R. Stecklein United States

Brian F. Kiesel United States

Michael A. Batey United Kingdom

Natalie Y.L. Ngoi Singapore

Andrea E. Wahner Hendrickson United States

Shona Nag India

Katherine Karakasis Canada

Michelle Ferguson

494 ×0.9

ONCOL

397 ×0.9

322 ×1.4

142 ×0.9

PRM

99 ×0.8

IMMUN

Citations per year, relative to Michelle Ferguson Michelle Ferguson (= 1×) peers Katherine Karakasis

Countries citing papers authored by Michelle Ferguson

Since Specialization

Citations

This map shows the geographic impact of Michelle Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Ferguson more than expected).

Fields of papers citing papers by Michelle Ferguson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Ferguson. The network helps show where Michelle Ferguson may publish in the future.

Co-authorship network of co-authors of Michelle Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Ferguson. A scholar is included among the top collaborators of Michelle Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Ferguson. Michelle Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferguson, Michelle, et al.. (2023). Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study. BMJ Open. 13(11). e076715–e076715. 1 indexed citations

Clarke, Rosemary G., et al.. (2022). Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer. British Journal of Cancer. 127(7). 1340–1351. 17 indexed citations

Roach, Mack, Jingbin Zhang, Andre Esteva, et al.. (2022). Prostate cancer risk in African American men evaluated via digital histopathology multi-modal deep learning models developed on NRG Oncology phase III clinical trials.. Journal of Clinical Oncology. 40(16_suppl). 108–108. 3 indexed citations

Frangou, Eleni, Gianfilippo Bertelli, Sharon Love, et al.. (2021). OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer. Gynecologic Oncology. 162(2). 431–439. 14 indexed citations

Drew, Yvette, Richard T. Penson, David M. O’Malley, et al.. (2020). 814MO Phase II study of olaparib (O) plus durvalumab (D) and bevacizumab (B) (MEDIOLA): Initial results in patients (pts) with non-germline BRCA-mutated (non-gBRCAm) platinum sensitive relapsed (PSR) ovarian cancer (OC). Annals of Oncology. 31. S615–S616. 47 indexed citations

Lee, Joseph K., et al.. (2019). The Value in Mental Health Screening for Individuals With Spinal Cord Injury: What Patients Tell Us. SHILAP Revista de lepidopterología. 2(1). 100032–100032. 3 indexed citations

Spiliopoulou, Pavlina, C. Bell, D. Stirling, et al.. (2018). Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience. BJOG An International Journal of Obstetrics & Gynaecology. 125(11). 1451–1458. 19 indexed citations

Singh, Jagdeep, et al.. (2016). 23 Surveillance and Incidence of Chemotherapy-Induced Cardiotoxicity in Breast Cancer: A Long Term Observational Study. A14.2–A15. 2 indexed citations

Vaidyanathan, Aparajitha, Anne‐Louise Gannon, Probir Chakravarty, et al.. (2016). ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells. British Journal of Cancer. 115(4). 431–441. 269 indexed citations

10.

Bauman, Glenn, Michelle Ferguson, Michael Lock, et al.. (2015). A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 92(4). 856–862. 57 indexed citations

11.

Ferguson, Michelle, George Rodrigues, Jeffrey Cao, & Glenn Bauman. (2014). Management of High-Grade Gliomas in the Elderly. Seminars in Radiation Oncology. 24(4). 279–288. 13 indexed citations

12.

Ferguson, Michelle, et al.. (2014). Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines. British Journal of Cancer. 111(6). 1150–1158. 92 indexed citations

13.

Ferguson, Michelle & George Rodrigues. (2013). Bridging the communication gap between oncologists and patients receiving palliative therapies.. PubMed. 2(4). 197–201. 2 indexed citations

14.

Smith, Gillian, Lori Shepherd, C. Simon Herrington, et al.. (2012). Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer. British Journal of Cancer. 107(8). 1327–1336. 26 indexed citations

15.

Ragupathy, Kalpana & Michelle Ferguson. (2011). Pattern and chemosensitivity of ovarian cancer in patients with BRCA1/2 mutations. Journal of Obstetrics and Gynaecology. 31(2). 178–179. 2 indexed citations

16.

Gourley, Charlie, Caroline O. Michie, Patricia Roxburgh, et al.. (2010). Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype. Journal of Clinical Oncology. 28(15). 2505–2511. 74 indexed citations

17.

Ferguson, Michelle, et al.. (2006). Late‐Onset Meningeal Metastases in Liposarcoma: A Case Report and Review of the Literature. Sarcoma. 2006(1). 23039–23039. 4 indexed citations

18.

Ferguson, Michelle & J A Dewar. (2002). Tamoxifen beyond 5 years—patients' decisions regarding entry to the aTTom trial. European Journal of Cancer. 38(14). 1857–1859. 6 indexed citations

19.

Ferguson, Michelle, et al.. (2001). The role of pro-drug therapy in the treatment of cancer. Drug Resistance Updates. 4(4). 225–232. 26 indexed citations

20.

MacMahon, Heber, et al.. (1986). Postoperative recurrence of lung cancer: detection by whole-body gallium scintigraphy. American Journal of Roentgenology. 147(5). 911–915. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact